2023-08-09 16:19:53 ET
-
Merus N.V. ( NASDAQ: MRUS ) plans to offer and sell its common shares through an underwritten public offering, the company said Wednesday.
-
All of the common shares are being offered by Merus.
-
The underwriters will have a 30-day option to purchase up to an additional 15% of the shares.
-
The pricing terms and number of shares to be offered were not disclosed.
-
The net proceeds from the offering, together with its existing cash, cash equivalents, and marketable securities, will be used to advance the clinical development of its product candidates, for preclinical research, and for technology development, among other things.
-
Jefferies, BofA Securities, Guggenheim Securities, and William Blair are acting as joint book-running managers for the offering.
-
Van Lanschot Kempen is acting as lead manager for the offering.
-
Shares -3.5% at $22.09 after hours.
For further details see:
Merus plans for stock offering, size not disclosed